The intraoperative staging systems in the management of peritoneal surface malignancy

被引:104
作者
Portilla, A. Gomez [1 ]
Shigeki, Kusamura [2 ]
Dario, Baratti [2 ]
Marcello, Deraco [2 ]
机构
[1] Hosp San Jose, Carcinomatosis Peritoneal Program, Vitoria 01008, Spain
[2] Ist Nazl Tumori Milano, IRCCS, Peritoneal Surface Malignancy Program, Milan, Italy
关键词
peritoneal cancer index; staging systems; peritoneal surface malignancy; peritoneal carcinomatosis;
D O I
10.1002/jso.21068
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The establishment of a rationale guideline for intraoperative staging system the extent of carcinomatosis is warranted. The quantitation of tumor found at the time of surgical exploration of the abdomen has proven to be of value in assessment of prognosis and treatment planning in patients with peritoneal carcinomatosis. Four different assessments systems have been employed more frequently, thus far. The advantages and disadvantages of each classification systems are described and discussed. The results of the Consensus of the last 5th International Workshop on Peritoneal Surface malignancy of Milan, December 2006 are presented.
引用
收藏
页码:228 / 231
页数:4
相关论文
共 30 条
[1]  
Beaujard AC, 2000, CANCER-AM CANCER SOC, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO
[2]  
2-J
[3]  
Elias D, 2001, CANCER, V92, P71, DOI 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO
[4]  
2-9
[5]  
Elias Dominique M, 2003, Surg Oncol Clin N Am, V12, P543, DOI 10.1016/S1055-3207(03)00049-8
[6]  
Fujimoto S, 1997, CANCER, V79, P884, DOI 10.1002/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO
[7]  
2-C
[8]  
GILLY FN, 1994, HEPATO-GASTROENTEROL, V41, P124
[9]  
GOMEZPORTILLA A, 1999, WORLD J SURG, V23, P23
[10]  
Hagiwara A, 1999, HEPATO-GASTROENTEROL, V46, P1673